Defective implantation and placentation: laying the blueprint for pregnancy complications
- 1 January 2006
- journal article
- review article
- Published by Elsevier BV in Reproductive BioMedicine Online
- Vol. 13 (4), 591-599
- https://doi.org/10.1016/s1472-6483(10)60649-9
Abstract
No abstract availableKeywords
This publication has 101 references indexed in Scilit:
- Thrombin Regulates Soluble fms-Like Tyrosine Kinase-1 (sFlt-1) Expression in First Trimester Decidua: Implications for PreeclampsiaThe American Journal of Pathology, 2007
- Interaction of Surfactant Protein A with Peroxiredoxin 6 Regulates Phospholipase A2 ActivityJournal of Biological Chemistry, 2006
- Threatened abortion: a risk factor for poor pregnancy outcome, a population-based screening studyAmerican Journal of Obstetrics and Gynecology, 2004
- Surfactant protein A, an innate immune factor, is expressed in the vaginal mucosa and is present in vaginal lavage fluidImmunology, 2003
- Multiple Female Reproductive Failures in Cyclooxygenase 2–Deficient MiceCell, 1997
- Blastocyst implantation depends on maternal expression of leukaemia inhibitory factorNature, 1992
- Gravidin, an endogenous inhibitor of phospholipase A2 activity, is a secretory component of IgABiochemical and Biophysical Research Communications, 1991
- Incidence of Early Loss of PregnancyNew England Journal of Medicine, 1988
- Partial purification and characterisation of two compounds from amniotic fluid which inhibit phospholipase activity in human endometrial cellsBiochemical and Biophysical Research Communications, 1985
- SUPPRESSION OF CONCENTRATION OF ENDOMETRIAL PROSTAGLANDIN IN EARLY INTRA-UTERINE AND ECTOPIC PREGNANCY IN WOMENJournal of Endocrinology, 1980